nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—ulcerative colitis	0.318	1	CbGaD
Clodronate—PTGS2—Olsalazine—ulcerative colitis	0.13	0.254	CbGbCtD
Clodronate—PTGS2—Balsalazide—ulcerative colitis	0.116	0.226	CbGbCtD
Clodronate—PTGS2—Mesalazine—ulcerative colitis	0.0927	0.181	CbGbCtD
Clodronate—PTGS2—Sulfasalazine—ulcerative colitis	0.0518	0.101	CbGbCtD
Clodronate—PTGS2—Triamcinolone—ulcerative colitis	0.0518	0.101	CbGbCtD
Clodronate—PTGS2—Betamethasone—ulcerative colitis	0.0444	0.0867	CbGbCtD
Clodronate—PTGS2—Dexamethasone—ulcerative colitis	0.0259	0.0504	CbGbCtD
Clodronate—SLC25A6—Influenza Virus Induced Apoptosis—TGFB1—ulcerative colitis	0.00716	0.145	CbGpPWpGaD
Clodronate—SLC25A6—epithelium—ulcerative colitis	0.00489	0.119	CbGeAlD
Clodronate—Oral disorder—Mercaptopurine—ulcerative colitis	0.00458	0.0611	CcSEcCtD
Clodronate—SLC25A5—epithelium—ulcerative colitis	0.00425	0.104	CbGeAlD
Clodronate—Acute myeloid leukaemia—Azathioprine—ulcerative colitis	0.0042	0.056	CcSEcCtD
Clodronate—SLC25A5—smooth muscle tissue—ulcerative colitis	0.0041	0.1	CbGeAlD
Clodronate—SLC25A6—lymphoid tissue—ulcerative colitis	0.00377	0.0919	CbGeAlD
Clodronate—SLC25A6—digestive system—ulcerative colitis	0.00372	0.0908	CbGeAlD
Clodronate—Bronchoconstriction—Budesonide—ulcerative colitis	0.00369	0.0491	CcSEcCtD
Clodronate—SLC25A6—Host Interactions with Influenza Factors—TGFB1—ulcerative colitis	0.00344	0.0698	CbGpPWpGaD
Clodronate—SLC25A5—lymphoid tissue—ulcerative colitis	0.00328	0.08	CbGeAlD
Clodronate—SLC25A5—digestive system—ulcerative colitis	0.00324	0.079	CbGeAlD
Clodronate—SLC25A4—Synaptic Vesicle Pathway—PARK7—ulcerative colitis	0.00323	0.0655	CbGpPWpGaD
Clodronate—SLC25A4—digestive system—ulcerative colitis	0.00303	0.074	CbGeAlD
Clodronate—SLC25A6—liver—ulcerative colitis	0.00277	0.0677	CbGeAlD
Clodronate—Acute leukaemia—Azathioprine—ulcerative colitis	0.00241	0.0322	CcSEcCtD
Clodronate—SLC25A5—liver—ulcerative colitis	0.00241	0.0589	CbGeAlD
Clodronate—SLC25A4—liver—ulcerative colitis	0.00226	0.0552	CbGeAlD
Clodronate—Local reaction—Nicotine—ulcerative colitis	0.00203	0.027	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.00186	0.0376	CbGpPWpGaD
Clodronate—Local reaction—Budesonide—ulcerative colitis	0.0014	0.0186	CcSEcCtD
Clodronate—Hepatocellular injury—Mercaptopurine—ulcerative colitis	0.00116	0.0154	CcSEcCtD
Clodronate—Local reaction—Mesalazine—ulcerative colitis	0.00113	0.0151	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.00113	0.0228	CbGpPWpGaD
Clodronate—Foetor hepaticus—Mesalazine—ulcerative colitis	0.00111	0.0148	CcSEcCtD
Clodronate—SLC25A5—Regulation of insulin secretion—ADCY5—ulcerative colitis	0.00109	0.022	CbGpPWpGaD
Clodronate—SLC25A4—Methyldopa—Mesalazine—ulcerative colitis	0.00107	0.278	CbGdCrCtD
Clodronate—Gastrointestinal symptom NOS—Mesalazine—ulcerative colitis	0.00107	0.0142	CcSEcCtD
Clodronate—Liver disorder—Mesalazine—ulcerative colitis	0.000922	0.0123	CcSEcCtD
Clodronate—SLC25A6—Regulation of insulin secretion—ADCY5—ulcerative colitis	0.00091	0.0185	CbGpPWpGaD
Clodronate—SLC25A5—Integration of energy metabolism—ADCY5—ulcerative colitis	0.000854	0.0173	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.000851	0.0173	CbGpPWpGaD
Clodronate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000841	0.0171	CbGpPWpGaD
Clodronate—Cardiac failure—Nicotine—ulcerative colitis	0.000834	0.0111	CcSEcCtD
Clodronate—Neoplasm malignant—Azathioprine—ulcerative colitis	0.000808	0.0108	CcSEcCtD
Clodronate—PTGS2—epithelium—ulcerative colitis	0.000801	0.0196	CbGeAlD
Clodronate—PTGS2—smooth muscle tissue—ulcerative colitis	0.000772	0.0188	CbGeAlD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000763	0.0155	CbGpPWpGaD
Clodronate—Wheezing—Budesonide—ulcerative colitis	0.00075	0.01	CcSEcCtD
Clodronate—Abdominal pain upper—Nicotine—ulcerative colitis	0.000744	0.00991	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—MUC3A—ulcerative colitis	0.000737	0.0149	CbGpPWpGaD
Clodronate—SLC25A6—Integration of energy metabolism—ADCY5—ulcerative colitis	0.000715	0.0145	CbGpPWpGaD
Clodronate—Proteinuria—Mesalazine—ulcerative colitis	0.000715	0.00953	CcSEcCtD
Clodronate—SLC25A4—Regulation of insulin secretion—ADCY5—ulcerative colitis	0.00071	0.0144	CbGpPWpGaD
Clodronate—Protein urine present—Mesalazine—ulcerative colitis	0.000705	0.0094	CcSEcCtD
Clodronate—Dysphagia—Nicotine—ulcerative colitis	0.000704	0.00938	CcSEcCtD
Clodronate—Bronchospasm—Nicotine—ulcerative colitis	0.000692	0.00923	CcSEcCtD
Clodronate—Hepatocellular injury—Azathioprine—ulcerative colitis	0.00069	0.0092	CcSEcCtD
Clodronate—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000687	0.179	CbGdCrCtD
Clodronate—Hypocalcaemia—Mesalazine—ulcerative colitis	0.000686	0.00915	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000665	0.0135	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000659	0.0134	CbGpPWpGaD
Clodronate—Hepatocellular injury—Mesalazine—ulcerative colitis	0.000628	0.00838	CcSEcCtD
Clodronate—PTGS2—lymphoid tissue—ulcerative colitis	0.000617	0.0151	CbGeAlD
Clodronate—PTGS2—digestive system—ulcerative colitis	0.000609	0.0149	CbGeAlD
Clodronate—Hypercalcaemia—Methylprednisolone—ulcerative colitis	0.000604	0.00805	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—MUC3A—ulcerative colitis	0.000575	0.0117	CbGpPWpGaD
Clodronate—Hepatic function abnormal—Azathioprine—ulcerative colitis	0.000573	0.00764	CcSEcCtD
Clodronate—Pharyngitis—Nicotine—ulcerative colitis	0.000559	0.00745	CcSEcCtD
Clodronate—SLC25A4—Integration of energy metabolism—ADCY5—ulcerative colitis	0.000559	0.0113	CbGpPWpGaD
Clodronate—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000546	0.0111	CbGpPWpGaD
Clodronate—Abdominal pain upper—Budesonide—ulcerative colitis	0.000512	0.00683	CcSEcCtD
Clodronate—Mediastinal disorder—Nicotine—ulcerative colitis	0.000508	0.00677	CcSEcCtD
Clodronate—Renal failure acute—Mesalazine—ulcerative colitis	0.000494	0.00659	CcSEcCtD
Clodronate—Renal impairment—Mesalazine—ulcerative colitis	0.000479	0.00639	CcSEcCtD
Clodronate—Bronchospasm—Budesonide—ulcerative colitis	0.000477	0.00636	CcSEcCtD
Clodronate—Anaemia—Mercaptopurine—ulcerative colitis	0.000468	0.00624	CcSEcCtD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000464	0.00941	CbGpPWpGaD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000457	0.00927	CbGpPWpGaD
Clodronate—PTGS2—liver—ulcerative colitis	0.000454	0.0111	CbGeAlD
Clodronate—Angioedema—Nicotine—ulcerative colitis	0.000448	0.00597	CcSEcCtD
Clodronate—Extravasation—Betamethasone—ulcerative colitis	0.000437	0.00583	CcSEcCtD
Clodronate—Extravasation—Dexamethasone—ulcerative colitis	0.000437	0.00583	CcSEcCtD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000437	0.00886	CbGpPWpGaD
Clodronate—SLC25A5—Host Interactions of HIV factors—CD4—ulcerative colitis	0.000433	0.00878	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000428	0.0057	CcSEcCtD
Clodronate—SLC25A5—Disease—CHP1—ulcerative colitis	0.000428	0.00867	CbGpPWpGaD
Clodronate—Blood creatinine increased—Mesalazine—ulcerative colitis	0.000427	0.0057	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.000423	0.00857	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.00042	0.00852	CbGpPWpGaD
Clodronate—Abdominal pain upper—Mesalazine—ulcerative colitis	0.000416	0.00555	CcSEcCtD
Clodronate—Wheezing—Triamcinolone—ulcerative colitis	0.000408	0.00545	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Mesalazine—ulcerative colitis	0.000402	0.00536	CcSEcCtD
Clodronate—Skin disorder—Mercaptopurine—ulcerative colitis	0.000401	0.00535	CcSEcCtD
Clodronate—Dysphagia—Mesalazine—ulcerative colitis	0.000394	0.00525	CcSEcCtD
Clodronate—Anorexia—Mercaptopurine—ulcerative colitis	0.000394	0.00525	CcSEcCtD
Clodronate—Pneumonia—Azathioprine—ulcerative colitis	0.000388	0.00517	CcSEcCtD
Clodronate—Bronchospasm—Mesalazine—ulcerative colitis	0.000388	0.00517	CcSEcCtD
Clodronate—Pharyngitis—Budesonide—ulcerative colitis	0.000385	0.00513	CcSEcCtD
Clodronate—Urinary tract disorder—Budesonide—ulcerative colitis	0.000383	0.00511	CcSEcCtD
Clodronate—Connective tissue disorder—Budesonide—ulcerative colitis	0.000381	0.00508	CcSEcCtD
Clodronate—Urethral disorder—Budesonide—ulcerative colitis	0.00038	0.00507	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000376	0.00763	CbGpPWpGaD
Clodronate—SLC25A6—Host Interactions of HIV factors—CD4—ulcerative colitis	0.000363	0.00735	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MUC2—ulcerative colitis	0.00036	0.0073	CbGpPWpGaD
Clodronate—Decreased appetite—Mercaptopurine—ulcerative colitis	0.000359	0.00479	CcSEcCtD
Clodronate—SLC25A6—Disease—CHP1—ulcerative colitis	0.000358	0.00727	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CHP1—ulcerative colitis	0.000358	0.00726	CbGpPWpGaD
Clodronate—Dyspnoea—Nicotine—ulcerative colitis	0.000357	0.00476	CcSEcCtD
Clodronate—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000356	0.00475	CcSEcCtD
Clodronate—Pneumonia—Mesalazine—ulcerative colitis	0.000353	0.00471	CcSEcCtD
Clodronate—Dyspepsia—Nicotine—ulcerative colitis	0.000352	0.0047	CcSEcCtD
Clodronate—Mediastinal disorder—Budesonide—ulcerative colitis	0.00035	0.00466	CcSEcCtD
Clodronate—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000345	0.00461	CcSEcCtD
Clodronate—Renal failure—Mesalazine—ulcerative colitis	0.000345	0.00461	CcSEcCtD
Clodronate—SLC25A5—Disease—SEL1L—ulcerative colitis	0.00034	0.00689	CbGpPWpGaD
Clodronate—Cardiac failure—Hydrocortisone—ulcerative colitis	0.000332	0.00443	CcSEcCtD
Clodronate—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000332	0.0863	CbGdCrCtD
Clodronate—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000327	0.0849	CbGdCrCtD
Clodronate—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000327	0.0849	CbGdCrCtD
Clodronate—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000319	0.083	CbGdCrCtD
Clodronate—Urticaria—Nicotine—ulcerative colitis	0.000318	0.00424	CcSEcCtD
Clodronate—Abdominal pain—Nicotine—ulcerative colitis	0.000316	0.00422	CcSEcCtD
Clodronate—Pharyngitis—Mesalazine—ulcerative colitis	0.000313	0.00417	CcSEcCtD
Clodronate—Cardiac failure—Methylprednisolone—ulcerative colitis	0.000312	0.00416	CcSEcCtD
Clodronate—Mediastinal disorder—Azathioprine—ulcerative colitis	0.000312	0.00416	CcSEcCtD
Clodronate—Anaemia—Budesonide—ulcerative colitis	0.000312	0.00416	CcSEcCtD
Clodronate—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000312	0.00415	CcSEcCtD
Clodronate—Connective tissue disorder—Mesalazine—ulcerative colitis	0.00031	0.00413	CcSEcCtD
Clodronate—Urethral disorder—Mesalazine—ulcerative colitis	0.000309	0.00412	CcSEcCtD
Clodronate—SLC25A5—Metabolism—DLD—ulcerative colitis	0.000309	0.00627	CbGpPWpGaD
Clodronate—Angioedema—Budesonide—ulcerative colitis	0.000309	0.00411	CcSEcCtD
Clodronate—SLC25A5—Disease—LTF—ulcerative colitis	0.000305	0.00618	CbGpPWpGaD
Clodronate—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000304	0.00616	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CHP1—ulcerative colitis	0.0003	0.00609	CbGpPWpGaD
Clodronate—Abdominal pain upper—Hydrocortisone—ulcerative colitis	0.000296	0.00395	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000286	0.00381	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000285	0.00381	CcSEcCtD
Clodronate—SLC25A6—Disease—SEL1L—ulcerative colitis	0.000285	0.00577	CbGpPWpGaD
Clodronate—Mediastinal disorder—Mesalazine—ulcerative colitis	0.000284	0.00379	CcSEcCtD
Clodronate—Cardiac failure—Betamethasone—ulcerative colitis	0.000284	0.00378	CcSEcCtD
Clodronate—Cardiac failure—Dexamethasone—ulcerative colitis	0.000284	0.00378	CcSEcCtD
Clodronate—SLC25A4—Host Interactions of HIV factors—CD4—ulcerative colitis	0.000283	0.00574	CbGpPWpGaD
Clodronate—Pruritus—Nicotine—ulcerative colitis	0.000283	0.00377	CcSEcCtD
Clodronate—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000283	0.00377	CcSEcCtD
Clodronate—SLC25A5—HIV Infection—CD4—ulcerative colitis	0.000281	0.0057	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MUC2—ulcerative colitis	0.000281	0.0057	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CHP1—ulcerative colitis	0.00028	0.00567	CbGpPWpGaD
Clodronate—Anaemia—Azathioprine—ulcerative colitis	0.000279	0.00372	CcSEcCtD
Clodronate—Diarrhoea—Nicotine—ulcerative colitis	0.000274	0.00365	CcSEcCtD
Clodronate—Infection—Budesonide—ulcerative colitis	0.000274	0.00365	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	0.000273	0.00555	CbGpPWpGaD
Clodronate—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.000269	0.00358	CcSEcCtD
Clodronate—Skin disorder—Budesonide—ulcerative colitis	0.000268	0.00357	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	0.000265	0.00538	CbGpPWpGaD
Clodronate—Anorexia—Budesonide—ulcerative colitis	0.000263	0.0035	CcSEcCtD
Clodronate—Vomiting—Mercaptopurine—ulcerative colitis	0.000263	0.0035	CcSEcCtD
Clodronate—Rash—Mercaptopurine—ulcerative colitis	0.00026	0.00347	CcSEcCtD
Clodronate—Dermatitis—Mercaptopurine—ulcerative colitis	0.00026	0.00347	CcSEcCtD
Clodronate—SLC25A6—Metabolism—DLD—ulcerative colitis	0.000259	0.00525	CbGpPWpGaD
Clodronate—Bronchospasm—Methylprednisolone—ulcerative colitis	0.000259	0.00345	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	0.000256	0.00519	CbGpPWpGaD
Clodronate—SLC25A6—Disease—LTF—ulcerative colitis	0.000255	0.00518	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000255	0.0034	CcSEcCtD
Clodronate—Vomiting—Nicotine—ulcerative colitis	0.000254	0.00339	CcSEcCtD
Clodronate—Anaemia—Mesalazine—ulcerative colitis	0.000254	0.00338	CcSEcCtD
Clodronate—Rash—Nicotine—ulcerative colitis	0.000252	0.00336	CcSEcCtD
Clodronate—Dermatitis—Nicotine—ulcerative colitis	0.000252	0.00336	CcSEcCtD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.000251	0.0051	CbGpPWpGaD
Clodronate—Angioedema—Mesalazine—ulcerative colitis	0.000251	0.00335	CcSEcCtD
Clodronate—Cardiac failure—Prednisone—ulcerative colitis	0.000247	0.0033	CcSEcCtD
Clodronate—Dyspnoea—Budesonide—ulcerative colitis	0.000246	0.00328	CcSEcCtD
Clodronate—Nausea—Mercaptopurine—ulcerative colitis	0.000245	0.00327	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000245	0.00496	CbGpPWpGaD
Clodronate—Infection—Azathioprine—ulcerative colitis	0.000244	0.00326	CcSEcCtD
Clodronate—Dyspepsia—Budesonide—ulcerative colitis	0.000243	0.00323	CcSEcCtD
Clodronate—Decreased appetite—Budesonide—ulcerative colitis	0.00024	0.00319	CcSEcCtD
Clodronate—Skin disorder—Azathioprine—ulcerative colitis	0.000239	0.00319	CcSEcCtD
Clodronate—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000238	0.00317	CcSEcCtD
Clodronate—SLC25A6—Influenza Infection—TGFB1—ulcerative colitis	0.000238	0.00482	CbGpPWpGaD
Clodronate—Nausea—Nicotine—ulcerative colitis	0.000238	0.00317	CcSEcCtD
Clodronate—SLC25A6—HIV Infection—CD4—ulcerative colitis	0.000236	0.00478	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CHP1—ulcerative colitis	0.000234	0.00475	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000232	0.0031	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.00023	0.00466	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—GHRL—ulcerative colitis	0.000226	0.00458	CbGpPWpGaD
Clodronate—Infection—Mesalazine—ulcerative colitis	0.000223	0.00297	CcSEcCtD
Clodronate—SLC25A4—Disease—SEL1L—ulcerative colitis	0.000222	0.00451	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000222	0.0045	CbGpPWpGaD
Clodronate—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.00022	0.00294	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.00022	0.00447	CbGpPWpGaD
Clodronate—Urticaria—Budesonide—ulcerative colitis	0.000219	0.00292	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	0.000218	0.00442	CbGpPWpGaD
Clodronate—Abdominal pain—Budesonide—ulcerative colitis	0.000218	0.0029	CcSEcCtD
Clodronate—Skin disorder—Mesalazine—ulcerative colitis	0.000218	0.0029	CcSEcCtD
Clodronate—SLC25A5—Disease—SLC11A1—ulcerative colitis	0.000217	0.0044	CbGpPWpGaD
Clodronate—Anorexia—Mesalazine—ulcerative colitis	0.000214	0.00285	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000213	0.00284	CcSEcCtD
Clodronate—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000212	0.00283	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	0.00021	0.00426	CbGpPWpGaD
Clodronate—Pharyngitis—Triamcinolone—ulcerative colitis	0.00021	0.00279	CcSEcCtD
Clodronate—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000207	0.00276	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000206	0.00417	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—DLD—ulcerative colitis	0.000202	0.0041	CbGpPWpGaD
Clodronate—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.0002	0.0521	CbGdCrCtD
Clodronate—Dyspnoea—Mesalazine—ulcerative colitis	0.0002	0.00266	CcSEcCtD
Clodronate—SLC25A4—Disease—LTF—ulcerative colitis	0.000199	0.00404	CbGpPWpGaD
Clodronate—Dyspepsia—Mesalazine—ulcerative colitis	0.000197	0.00263	CcSEcCtD
Clodronate—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000197	0.0512	CbGdCrCtD
Clodronate—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000197	0.0512	CbGdCrCtD
Clodronate—SLC25A5—Disease—MAML2—ulcerative colitis	0.000195	0.00396	CbGpPWpGaD
Clodronate—Pruritus—Budesonide—ulcerative colitis	0.000195	0.0026	CcSEcCtD
Clodronate—Decreased appetite—Mesalazine—ulcerative colitis	0.000195	0.0026	CcSEcCtD
Clodronate—Abdominal pain—Azathioprine—ulcerative colitis	0.000194	0.00259	CcSEcCtD
Clodronate—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000193	0.00258	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000193	0.00392	CbGpPWpGaD
Clodronate—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000193	0.0501	CbGdCrCtD
Clodronate—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.00019	0.00253	CcSEcCtD
Clodronate—Diarrhoea—Budesonide—ulcerative colitis	0.000189	0.00251	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	0.000188	0.00381	CbGpPWpGaD
Clodronate—SLC25A4—HIV Infection—CD4—ulcerative colitis	0.000184	0.00373	CbGpPWpGaD
Clodronate—Angioedema—Prednisolone—ulcerative colitis	0.000183	0.00244	CcSEcCtD
Clodronate—SLC25A6—Disease—SLC11A1—ulcerative colitis	0.000182	0.00369	CbGpPWpGaD
Clodronate—Angioedema—Hydrocortisone—ulcerative colitis	0.000178	0.00238	CcSEcCtD
Clodronate—Urticaria—Mesalazine—ulcerative colitis	0.000178	0.00237	CcSEcCtD
Clodronate—Abdominal pain—Mesalazine—ulcerative colitis	0.000177	0.00236	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—GHRL—ulcerative colitis	0.000176	0.00358	CbGpPWpGaD
Clodronate—Vomiting—Budesonide—ulcerative colitis	0.000175	0.00234	CcSEcCtD
Clodronate—Rash—Budesonide—ulcerative colitis	0.000174	0.00232	CcSEcCtD
Clodronate—Dermatitis—Budesonide—ulcerative colitis	0.000174	0.00231	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	0.00017	0.00346	CbGpPWpGaD
Clodronate—Diarrhoea—Azathioprine—ulcerative colitis	0.000168	0.00224	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	0.000168	0.00341	CbGpPWpGaD
Clodronate—Angioedema—Triamcinolone—ulcerative colitis	0.000168	0.00224	CcSEcCtD
Clodronate—Angioedema—Methylprednisolone—ulcerative colitis	0.000168	0.00224	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	0.000167	0.00338	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000165	0.0022	CcSEcCtD
Clodronate—Connective tissue disorder—Prednisone—ulcerative colitis	0.000164	0.00219	CcSEcCtD
Clodronate—Nausea—Budesonide—ulcerative colitis	0.000164	0.00218	CcSEcCtD
Clodronate—SLC25A6—Disease—MAML2—ulcerative colitis	0.000164	0.00332	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CALM3—ulcerative colitis	0.000161	0.00326	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.00016	0.00324	CbGpPWpGaD
Clodronate—Pruritus—Mesalazine—ulcerative colitis	0.000159	0.00211	CcSEcCtD
Clodronate—Infection—Hydrocortisone—ulcerative colitis	0.000158	0.00211	CcSEcCtD
Clodronate—Vomiting—Azathioprine—ulcerative colitis	0.000156	0.00209	CcSEcCtD
Clodronate—Rash—Azathioprine—ulcerative colitis	0.000155	0.00207	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000155	0.00207	CcSEcCtD
Clodronate—Dermatitis—Azathioprine—ulcerative colitis	0.000155	0.00207	CcSEcCtD
Clodronate—Skin disorder—Hydrocortisone—ulcerative colitis	0.000155	0.00206	CcSEcCtD
Clodronate—Diarrhoea—Mesalazine—ulcerative colitis	0.000153	0.00204	CcSEcCtD
Clodronate—Angioedema—Betamethasone—ulcerative colitis	0.000152	0.00203	CcSEcCtD
Clodronate—Angioedema—Dexamethasone—ulcerative colitis	0.000152	0.00203	CcSEcCtD
Clodronate—Anorexia—Hydrocortisone—ulcerative colitis	0.000152	0.00203	CcSEcCtD
Clodronate—SLC25A5—Metabolism—PTGS1—ulcerative colitis	0.000149	0.00303	CbGpPWpGaD
Clodronate—Infection—Triamcinolone—ulcerative colitis	0.000149	0.00199	CcSEcCtD
Clodronate—Infection—Methylprednisolone—ulcerative colitis	0.000149	0.00198	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	0.000148	0.003	CbGpPWpGaD
Clodronate—Nausea—Azathioprine—ulcerative colitis	0.000146	0.00195	CcSEcCtD
Clodronate—Skin disorder—Methylprednisolone—ulcerative colitis	0.000145	0.00194	CcSEcCtD
Clodronate—Vomiting—Mesalazine—ulcerative colitis	0.000142	0.0019	CcSEcCtD
Clodronate—SLC25A4—Disease—SLC11A1—ulcerative colitis	0.000142	0.00288	CbGpPWpGaD
Clodronate—Rash—Mesalazine—ulcerative colitis	0.000141	0.00188	CcSEcCtD
Clodronate—Dermatitis—Mesalazine—ulcerative colitis	0.000141	0.00188	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—MMP1—ulcerative colitis	0.00014	0.00285	CbGpPWpGaD
Clodronate—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00014	0.00187	CcSEcCtD
Clodronate—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000139	0.00185	CcSEcCtD
Clodronate—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000138	0.00183	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	0.000138	0.00279	CbGpPWpGaD
Clodronate—Infection—Dexamethasone—ulcerative colitis	0.000135	0.0018	CcSEcCtD
Clodronate—Infection—Betamethasone—ulcerative colitis	0.000135	0.0018	CcSEcCtD
Clodronate—SLC25A6—Disease—CALM3—ulcerative colitis	0.000135	0.00273	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CALM3—ulcerative colitis	0.000135	0.00273	CbGpPWpGaD
Clodronate—Anaemia—Prednisone—ulcerative colitis	0.000134	0.00179	CcSEcCtD
Clodronate—Dyspnoea—Triamcinolone—ulcerative colitis	0.000134	0.00178	CcSEcCtD
Clodronate—Nausea—Mesalazine—ulcerative colitis	0.000133	0.00177	CcSEcCtD
Clodronate—Angioedema—Prednisone—ulcerative colitis	0.000133	0.00177	CcSEcCtD
Clodronate—Dyspepsia—Triamcinolone—ulcerative colitis	0.000132	0.00176	CcSEcCtD
Clodronate—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000132	0.00176	CcSEcCtD
Clodronate—Anorexia—Dexamethasone—ulcerative colitis	0.00013	0.00173	CcSEcCtD
Clodronate—Anorexia—Betamethasone—ulcerative colitis	0.00013	0.00173	CcSEcCtD
Clodronate—Urticaria—Prednisolone—ulcerative colitis	0.00013	0.00173	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.000129	0.00262	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.000128	0.0026	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MAML2—ulcerative colitis	0.000128	0.00259	CbGpPWpGaD
Clodronate—Urticaria—Hydrocortisone—ulcerative colitis	0.000127	0.00169	CcSEcCtD
Clodronate—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000126	0.00168	CcSEcCtD
Clodronate—SLC25A6—Metabolism—PTGS1—ulcerative colitis	0.000125	0.00254	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000123	0.00164	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	0.000121	0.00246	CbGpPWpGaD
Clodronate—Dyspepsia—Betamethasone—ulcerative colitis	0.00012	0.0016	CcSEcCtD
Clodronate—Dyspepsia—Dexamethasone—ulcerative colitis	0.00012	0.0016	CcSEcCtD
Clodronate—Urticaria—Triamcinolone—ulcerative colitis	0.000119	0.00159	CcSEcCtD
Clodronate—Urticaria—Methylprednisolone—ulcerative colitis	0.000119	0.00159	CcSEcCtD
Clodronate—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000118	0.00158	CcSEcCtD
Clodronate—Decreased appetite—Dexamethasone—ulcerative colitis	0.000118	0.00158	CcSEcCtD
Clodronate—Decreased appetite—Betamethasone—ulcerative colitis	0.000118	0.00158	CcSEcCtD
Clodronate—Infection—Prednisone—ulcerative colitis	0.000118	0.00157	CcSEcCtD
Clodronate—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000118	0.00157	CcSEcCtD
Clodronate—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000118	0.00157	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000117	0.00237	CbGpPWpGaD
Clodronate—SLC25A5—Disease—ADCY5—ulcerative colitis	0.000117	0.00236	CbGpPWpGaD
Clodronate—Skin disorder—Prednisone—ulcerative colitis	0.000115	0.00154	CcSEcCtD
Clodronate—Anorexia—Prednisone—ulcerative colitis	0.000113	0.00151	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	0.000113	0.00229	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CALM3—ulcerative colitis	0.000113	0.00229	CbGpPWpGaD
Clodronate—Pruritus—Hydrocortisone—ulcerative colitis	0.000113	0.0015	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	0.00011	0.00224	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MMP1—ulcerative colitis	0.00011	0.00222	CbGpPWpGaD
Clodronate—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000109	0.00145	CcSEcCtD
Clodronate—Urticaria—Betamethasone—ulcerative colitis	0.000108	0.00144	CcSEcCtD
Clodronate—Urticaria—Dexamethasone—ulcerative colitis	0.000108	0.00144	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.000108	0.00219	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	0.000108	0.00219	CbGpPWpGaD
Clodronate—Abdominal pain—Dexamethasone—ulcerative colitis	0.000108	0.00144	CcSEcCtD
Clodronate—Abdominal pain—Betamethasone—ulcerative colitis	0.000108	0.00144	CcSEcCtD
Clodronate—Pruritus—Triamcinolone—ulcerative colitis	0.000106	0.00142	CcSEcCtD
Clodronate—Pruritus—Methylprednisolone—ulcerative colitis	0.000106	0.00141	CcSEcCtD
Clodronate—SLC25A4—Disease—CALM3—ulcerative colitis	0.000105	0.00213	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ABCB1—ulcerative colitis	0.000105	0.00212	CbGpPWpGaD
Clodronate—Dyspepsia—Prednisone—ulcerative colitis	0.000104	0.00139	CcSEcCtD
Clodronate—Decreased appetite—Prednisone—ulcerative colitis	0.000103	0.00137	CcSEcCtD
Clodronate—Rash—Prednisolone—ulcerative colitis	0.000103	0.00137	CcSEcCtD
Clodronate—Dermatitis—Prednisolone—ulcerative colitis	0.000103	0.00137	CcSEcCtD
Clodronate—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000102	0.00137	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.000102	0.00206	CbGpPWpGaD
Clodronate—Vomiting—Hydrocortisone—ulcerative colitis	0.000101	0.00135	CcSEcCtD
Clodronate—Rash—Hydrocortisone—ulcerative colitis	0.0001	0.00134	CcSEcCtD
Clodronate—Dermatitis—Hydrocortisone—ulcerative colitis	0.0001	0.00134	CcSEcCtD
Clodronate—SLC25A4—Metabolism—PTGS1—ulcerative colitis	9.78e-05	0.00198	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ADCY5—ulcerative colitis	9.77e-05	0.00198	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ADCY5—ulcerative colitis	9.76e-05	0.00198	CbGpPWpGaD
Clodronate—Nausea—Prednisolone—ulcerative colitis	9.69e-05	0.00129	CcSEcCtD
Clodronate—Pruritus—Dexamethasone—ulcerative colitis	9.63e-05	0.00128	CcSEcCtD
Clodronate—Pruritus—Betamethasone—ulcerative colitis	9.63e-05	0.00128	CcSEcCtD
Clodronate—Vomiting—Triamcinolone—ulcerative colitis	9.54e-05	0.00127	CcSEcCtD
Clodronate—Vomiting—Methylprednisolone—ulcerative colitis	9.52e-05	0.00127	CcSEcCtD
Clodronate—Nausea—Hydrocortisone—ulcerative colitis	9.47e-05	0.00126	CcSEcCtD
Clodronate—Rash—Triamcinolone—ulcerative colitis	9.46e-05	0.00126	CcSEcCtD
Clodronate—Dermatitis—Triamcinolone—ulcerative colitis	9.45e-05	0.00126	CcSEcCtD
Clodronate—Rash—Methylprednisolone—ulcerative colitis	9.44e-05	0.00126	CcSEcCtD
Clodronate—Dermatitis—Methylprednisolone—ulcerative colitis	9.43e-05	0.00126	CcSEcCtD
Clodronate—Urticaria—Prednisone—ulcerative colitis	9.42e-05	0.00126	CcSEcCtD
Clodronate—Abdominal pain—Prednisone—ulcerative colitis	9.37e-05	0.00125	CcSEcCtD
Clodronate—Diarrhoea—Dexamethasone—ulcerative colitis	9.32e-05	0.00124	CcSEcCtD
Clodronate—Diarrhoea—Betamethasone—ulcerative colitis	9.32e-05	0.00124	CcSEcCtD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	9.22e-05	0.00187	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CXCL8—ulcerative colitis	9.03e-05	0.00183	CbGpPWpGaD
Clodronate—Nausea—Triamcinolone—ulcerative colitis	8.91e-05	0.00119	CcSEcCtD
Clodronate—Nausea—Methylprednisolone—ulcerative colitis	8.89e-05	0.00119	CcSEcCtD
Clodronate—SLC25A4—Metabolism—CALM3—ulcerative colitis	8.8e-05	0.00179	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCB1—ulcerative colitis	8.77e-05	0.00178	CbGpPWpGaD
Clodronate—Vomiting—Dexamethasone—ulcerative colitis	8.66e-05	0.00115	CcSEcCtD
Clodronate—Vomiting—Betamethasone—ulcerative colitis	8.66e-05	0.00115	CcSEcCtD
Clodronate—Rash—Betamethasone—ulcerative colitis	8.58e-05	0.00114	CcSEcCtD
Clodronate—Rash—Dexamethasone—ulcerative colitis	8.58e-05	0.00114	CcSEcCtD
Clodronate—Dermatitis—Betamethasone—ulcerative colitis	8.58e-05	0.00114	CcSEcCtD
Clodronate—Dermatitis—Dexamethasone—ulcerative colitis	8.58e-05	0.00114	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	8.46e-05	0.00172	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	8.4e-05	0.0017	CbGpPWpGaD
Clodronate—Pruritus—Prednisone—ulcerative colitis	8.39e-05	0.00112	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	8.37e-05	0.0017	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ADCY5—ulcerative colitis	8.18e-05	0.00166	CbGpPWpGaD
Clodronate—Diarrhoea—Prednisone—ulcerative colitis	8.11e-05	0.00108	CcSEcCtD
Clodronate—Nausea—Betamethasone—ulcerative colitis	8.09e-05	0.00108	CcSEcCtD
Clodronate—Nausea—Dexamethasone—ulcerative colitis	8.09e-05	0.00108	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	8.03e-05	0.00163	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	7.86e-05	0.00159	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	7.74e-05	0.00157	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	7.72e-05	0.00157	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ADCY5—ulcerative colitis	7.63e-05	0.00155	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	7.62e-05	0.00155	CbGpPWpGaD
Clodronate—Vomiting—Prednisone—ulcerative colitis	7.54e-05	0.00101	CcSEcCtD
Clodronate—Rash—Prednisone—ulcerative colitis	7.48e-05	0.000997	CcSEcCtD
Clodronate—Dermatitis—Prednisone—ulcerative colitis	7.47e-05	0.000996	CcSEcCtD
Clodronate—SLC25A5—Metabolism—PPARG—ulcerative colitis	7.28e-05	0.00148	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	7.28e-05	0.00148	CbGpPWpGaD
Clodronate—SLC25A5—Disease—JAK2—ulcerative colitis	7.27e-05	0.00147	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CXCL8—ulcerative colitis	7.05e-05	0.00143	CbGpPWpGaD
Clodronate—Nausea—Prednisone—ulcerative colitis	7.04e-05	0.000939	CcSEcCtD
Clodronate—SLC25A5—Disease—CD4—ulcerative colitis	6.89e-05	0.0014	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	6.89e-05	0.0014	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCB1—ulcerative colitis	6.85e-05	0.00139	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—ulcerative colitis	6.84e-05	0.00139	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALB—ulcerative colitis	6.55e-05	0.00133	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	6.43e-05	0.0013	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ADCY5—ulcerative colitis	6.39e-05	0.0013	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	6.11e-05	0.00124	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARG—ulcerative colitis	6.1e-05	0.00124	CbGpPWpGaD
Clodronate—SLC25A6—Disease—JAK2—ulcerative colitis	6.09e-05	0.00124	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CD4—ulcerative colitis	5.77e-05	0.00117	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—ulcerative colitis	5.73e-05	0.00116	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—ulcerative colitis	5.73e-05	0.00116	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	5.68e-05	0.00115	CbGpPWpGaD
Clodronate—PTGS2—Disease—CHP1—ulcerative colitis	5.53e-05	0.00112	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALB—ulcerative colitis	5.49e-05	0.00111	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	5.45e-05	0.0011	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	5.43e-05	0.0011	CbGpPWpGaD
Clodronate—SLC25A5—Disease—STAT3—ulcerative colitis	5.33e-05	0.00108	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	5.14e-05	0.00104	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	5e-05	0.00101	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—ulcerative colitis	4.94e-05	0.001	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—ulcerative colitis	4.8e-05	0.000973	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARG—ulcerative colitis	4.76e-05	0.000966	CbGpPWpGaD
Clodronate—SLC25A4—Disease—JAK2—ulcerative colitis	4.75e-05	0.000964	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CHP1—ulcerative colitis	4.63e-05	0.000939	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CD4—ulcerative colitis	4.51e-05	0.000914	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—ulcerative colitis	4.47e-05	0.000907	CbGpPWpGaD
Clodronate—SLC25A6—Disease—STAT3—ulcerative colitis	4.47e-05	0.000906	CbGpPWpGaD
Clodronate—PTGS2—Disease—SEL1L—ulcerative colitis	4.39e-05	0.000891	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.34e-05	0.00088	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—ulcerative colitis	4.28e-05	0.000869	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	4.23e-05	0.000859	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—ulcerative colitis	4.14e-05	0.00084	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	4.03e-05	0.000818	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DLD—ulcerative colitis	4e-05	0.000811	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	3.95e-05	0.000802	CbGpPWpGaD
Clodronate—PTGS2—Disease—LTF—ulcerative colitis	3.94e-05	0.000799	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—ulcerative colitis	3.75e-05	0.00076	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—ulcerative colitis	3.73e-05	0.000756	CbGpPWpGaD
Clodronate—SLC25A4—Disease—STAT3—ulcerative colitis	3.49e-05	0.000708	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	3.49e-05	0.000707	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	3.46e-05	0.000701	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—ulcerative colitis	3.23e-05	0.000656	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	3.19e-05	0.000647	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—ulcerative colitis	3.12e-05	0.000633	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.88e-05	0.000584	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC11A1—ulcerative colitis	2.81e-05	0.000569	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.69e-05	0.000545	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAML2—ulcerative colitis	2.52e-05	0.000512	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—ulcerative colitis	2.44e-05	0.000494	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.37e-05	0.000481	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.11e-05	0.000429	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALM3—ulcerative colitis	2.08e-05	0.000421	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTGS1—ulcerative colitis	1.93e-05	0.000392	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.9e-05	0.000386	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CALM3—ulcerative colitis	1.74e-05	0.000353	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADCY5—ulcerative colitis	1.51e-05	0.000306	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—ulcerative colitis	1.35e-05	0.000274	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADCY5—ulcerative colitis	1.26e-05	0.000256	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARG—ulcerative colitis	9.42e-06	0.000191	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAK2—ulcerative colitis	9.4e-06	0.000191	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD4—ulcerative colitis	8.91e-06	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—ulcerative colitis	8.47e-06	0.000172	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT3—ulcerative colitis	6.9e-06	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—ulcerative colitis	6.4e-06	0.00013	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—ulcerative colitis	4.82e-06	9.77e-05	CbGpPWpGaD
